share_log

葫芦娃:获阿加曲班注射液药品注册证书

Hainan Huluwa Pharmaceutical Group: Obtained the registration certificate for the injection of Ajupanib.

Breakings ·  Nov 5 17:36

Hainan Huluwa Pharmaceutical Group announcement, the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the Ajupanib injection. This pharmaceutical is an injection, classified as a Category 4 chemical drug, with a specification of 2ml:10mg.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment